Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Someone purchased just to see if it works....Just a very slow day.
I actually expected the opposite today, higher volume, with anticipation of FDA news. Well, it looks like a waiting game again.
No volume this morning. What's wrong with .115? I'd buy at that price if I had some money. Looks like a really slow Friday.
Come on guys, are you serious? Why is it that nothing seems good enough? We finally get great news that the sepsis is still moving, but we move to the next complaint. (Sepsis alone is great by itself) Do you really believe that we will not get the IDE FDA approval with a few weeks, or month? I do.......Do you really believe that the India studies are forgotten? I believe the testing in India is what will produce FDA approval for studies, which was well worth it, India or not..IMO. Also, exosomes are big, huge, and if I was the CEO I would also skip to what would be my real money maker if I knew I had an in within the market. It's all there, lets just wait for the outcome. This is like politics, let the big guys do their jobs. We're investors, not on the board. I haven't seen a better position then now. Again, not a better time then now.... Ya, I've seen .68, .40, .30 and also .05, but we didn't have then what we have now at .10..... It's coming and I've waited and I'll still wait because there is momentum. This is coming from a believer.....and that's why I invested.....it's all good :)
Tumor Microvesicles and Exosomes
It's nice to see Aethlon getting credit for their exosome work. Check references #9 at the bottom of the article.
https://confluence.cornell.edu/display/CE/Tumor+Microvesicles+and+Exosomes
I'm just excited things are positive and moving forward. I have no complaints and plan to lower my average in the coming weeks. It's all good...
I'm just excited things are positive and moving forward. I have no complaints and plan to lower my average in the coming weeks. It's all good...
Something's going on. It's not like they haven't had several months to work on it. Today is great news, without the news. :)
I'll stop. Just wanted to shed some positive light on the possibilities.
IMO the longer the silence the better if there are talks of an acquisition. We're in a very interesting position here. Name one company that is comparable to Aethlon?, given a "Single therapy that could address more than one disease indication" As mentioned, multiple "Shots on Goal."
Also keep in mind that Aethlon has amazing Hep C test results and is the only company that has the "First therapeutic strategy to address tumor-secreted exosomes." Also keep in mind we have strong patents for years. What that worth?
Next, what do we really know as shareholders? Do we know for sure that Aethlon is still not in the running for the DARPA grant, with partnerships? What's really up with the FDA? I know that Aethlon has been in continuous communication with them, based on prior PR's, so with that in mind could it be possible that Aethlon feels confident or may even already know the outcome?
Put all of this together, plus add a possible acquisition or partnership and what is Aethlon and its multiple "Shots on goal' worth?
I would agree with most if this was a normal biotech company, but Aethlon is not normal, far from the ordinary drug or device company. So, let just say that Aethlon had everything in order and the dinner table is beautifully set, what's it worth? What could this technolgy be worth in the right hands in the next 5, 10, or 15 years? How many lives could you save in Sepsis, Hep C, HIV, and cancer with one Hemopurifier? I have high hopes and am obviously thinking possitive, why not? The Hemopurifier rocks...Is 10 billion a lot to pay, when my return could be triple or more in 10 years or less? Who knows, but how much is it worth to SAVE LIVES.
Again, we are in a very interesting position :)
I say lets keep to what we have and not assume the worst. Here are some quotes I'm sticking with from JJ's shareholders note.
"I ask you to consider some of our milestone achievements since September 30th, 2011. Milestone achievements that many biotechnology or medical device organizations would envy."
"We reported our first Hepatitis-C (HCV) efficacy data related to the use of our Hemopurifier® as an adjunct to optimize the benefit of standard of care drug therapy. The results exceeded expectations as a three-treatment Hemopurifier® protocol was demonstrated to reduce viral load to undetectable levels in as little as seven days. Since September 30th, 2011, organizations with clinical stage adjunct therapies have been acquired for a much as $11 Billion."
[Why add that other adjunct therapies have been acquired for as much as $11 Billion? I feel it's an interesting comment coming from a small company at about .08 at the time]
"Tumor-secreted exosomes have been discovered to play a vital role in cancer progression and it has recently become clear that a successful war against cancer will need to address these particles. Our Hemopurifier® is the first therapeutic candidate to address tumor-secreted exosomes."
[I underlined what I thought was important. I also think that exosomes are now the front runner to Hep C at this point, which is clear by the recent PR's]
"We expanded our intellectual property portfolio of pending and issued patents. As the result of our early exosome research, we were recently issued a patent that protects our cancer treatment strategy in the United States for the next two decades"
"We received the support of highly regarded thought leaders from the extracorporeal, sepsis, and cancer field who agreed to join our science advisory board."
[Why support a company that's on it's way out?]
"In closing, I am forever grateful to those shareholders that have loyally supported our endeavors even in the darkest moments. Your belief validates many sacrifices and inspires the strength to continue waging every fight necessary to ensure our innovation has the opportunity to save lives."
["SAVE LIVES" is Aethlon new motto..]
So, here is another dark moment, or is it? Again, I say things are happening and the silence may seem dark, but IMO we are close to seeing sunlight. Stay positive and hang in there so Aethlon can SAVE LIVES :)
That could also be true, but the prior work up tends to build towards an acquistion IMO. Aethlon puts out PR related to Exosomes and talks about "Multiple shots on goal" then we have a large build up on PPS, which most agreed was not a pump. So, what was it? and directly afterwards we have over a month plus of silence. I'm leaning more towards positive news. again IMO.
This just may be silence as they work on partnerships or an acquistion deal.
Nevermind, it's posted on Aethlon website. I'm starting to lose it....Maybe some good news would help.
I don't believe I've seen this PDF presentation before. If someone has posted this prior I apologize. It's Rod Kenley's presenation at the 15th International Conference On Dialysis. Whats interesting is frame 47, where he talks about exosomes related to sepsis. Again, I just don't recall this stuff.
"Rod Kenley Disclosure of Relevant Financial Relationships"
filecache.drivetheweb.com/.../01-23-2013+Kenley+RRI+Presentation
So, any ideas? This is interesting. Do you think the silence is good, or bad? What really causes silence within a company? I personally think its good, especially after doing a re-run of the past few months of press and presentations. I actually think we're getting what most have ask for....think? What was it that most complained about before the silence? What was it that most wanted before the silence? Anyway, each day of no news is only one day closer......please review the last presentations and PR before answering.....silence is not our enemy, or is it? Enterested in your comments....but remember that we were all excited (Vegas) and waiting before the silence... Bad or good? Ummmmm.
It's been a few weeks of silence and all of a sudden longs are starting to second guess? grant, no grant? Aethlon, no Aethlon? Hep C, no Hep C? etc. We can assume the worst, but in the end it will be a waste of time and energy. For all we know Aethlon is working on something and must stay in silence until completed. Who knows? I doudt anyone of you are going to sell at this point, right? So we wait patiently no matter what the outcome. If it's great news we will all forget these posts and move on to the next milestone, if not most of us were locked in (Stuck)anyway. We've had silence many times and we're all still here. I have faith as a shareholder in this stock, or I would have never started purchasing and purchasing shares. I also feel confident in JJ. In my last five years as a shareholder we have had slow but positive movement. Anyway, I'm staying LONG and have confidence that the silence is to our benefit. Each day is a day closer to some type of news, good or bad.. This is what makes a true LONG, a long slow sometimes quiet road.....IMO
There is something up? A couple weeks ago we had primarily exosome PR, actually 2 in a row and then after the Darpa award there has been nothing for two weeks..... Aethlon is in waiting mode......silence is really are friend right now. They're holding off on PR for the big one. This is unusual, and the next PR is worth the wait. This is all good.... ALL GOOD.... :)
There is still hope so keeps your heads up and money in. Aethlon hit all its milestones well on time, so how is it even possible that the project would not continue without Aethlon. If JJ even thought a little about not getting involved in the grant we would have had some signs, such as not talking about it in every prior presentation. We're in this, So be patient...IMO and holding strong as usual. Just the fact that we haven't had the little PR's like a couple of weeks ago makes me feel that the silence is a very good thing. I just think they are just waiting their turn. It's all good and very optimistic.
Hi PhilB1, I'm just curious as you are as to what's really going on here. I don't think this is a pump & dump, but with no updated news I'm a little worried. I find it interesting that last week Aethlon was providing PR, but now after the recent Darpa release there is nothing. I was also a little shocked that Aethlon did'nt release any news this morning to let us longs know this is'nt a pump & dump. Well, all I know is that we need to get some real PR soon. I'm excited and worried at the same time...
Lee, It's all good and we will all be in Vegas soon. Yes, I believe we all agreed on $5, so we need to get a move on. It's all good :) See you in Vegas.....Soon we will see FDA approval and the Gov. grant..
It appears with the last two consecutive PR's that Aethlon is trying to gain momentum for the three point jump shot. If I was the coach I would have the team make the shot before a steal or the ending buzzer. Lets not put these two passes to waste... We can win this game :)
This will be a big waste of good PR if Aethlon doesn't followup immediately with a three point jump shot. The team makes the great passes, but can not follow through with any points. They've added some new players, so lets start seeing some hoops.
RNA Fragments May Yield Rapid, Accurate Cancer Diagnosis
http://news.yahoo.com/rna-fragments-may-yield-rapid-accurate-cancer-diagnosis-213000243.html
I believe ELLSA is around 90% accurate from what I recall. Maybe we can actually find a buyer?
Exosomes as Biomarkers for Brain Tumors - by Xandra O. Breakefield, PhD
I was thinking the same thing.....Interesting, especially after some good news.
Why would JJ accidentally say 12 mil. and then correct himself and say 2 mil. There is a 10 mil. dollar difference. He has not made this mistake before when it comes to numbers... My thinking is that JJ already knows the payout for Darpa and made a mistake during his presentation He also makes it obvious that the Darpa contract continues, as well as, something big for exosomes. He gave so many hints...So many hints..... IMO...Why put so much emphasis on the Darpa contract plus exosomes if it stops here? This is going to get real good.....again IMO...and excited. :)
Hepatitis C cure set for a break out.
http://ireport.cnn.com/docs/DOC-905798?ref=feeds%2Flatest
Surprising Discovery Identifies New Approach to Suppress Spread of Cancer
http://biotechnologyfocus.ca/?p=3354&utm_source=rss&utm_medium=rss&utm_campaign=surprising-discovery-identifies-new-approach-to-suppress-spread-of-cancer
Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells
http://www.nature.com/mt/journal/v21/n1/full/mt2012180a.html
My guess is YES. It appears to me that JJ is just slowly setting the stage for what's coming in regards to exosomes. If exosomes are the paradigm shift in cancer then Aethlon will be well positioned.
I think this month will be very interesting. I'm expecting more great india patient results, IDE submittal, and hopefully Darpa grant infomation. The silence is over....IMO
In regards to Hep C, I love this statement....
"our Hemopurifier® synergistically combines with drug therapy to accelerate the achievement of undetectable viral load."
Notice the "UNDETECTABLE VIRAL LOAD"I can't wait to hear the updated patient data in India.
Well, my guess was wrong. Lets hope they announce great patient data and IDE submittal by year-end.
"Aethlon expects to report updated results, including new patient data from this study in the near future. The Company also disclosed it is presently incorporating new patient data within investigational device exemption (IDE) that is expected to be submitted to FDA by year-end in an effort to gain approval to initiate HCV clinical programs in the United States."
As far as starting up in India. Wouldn't it be wise to advertise, becides one news announcement? Treatment is treatment and they need to get the word out. IMO...
Disagree....their both very important. FDA will set us up for hep c and Exosomes in the US. BIG MOVE....IMO...
It seems real easy to show doudt when dealing with the unknown. We even fall back on prior negatives to somehow make it easier to understand current silence.
JJ and Aethlon has given us no reason to doudt their direction. Lack of communication is not a sign a failure. Yes, they have minimal funds if any, but that has been since day one, that I recall. So,
1. Working on a Sepsis program through Darpa.(First phase was great and ahead of schedule) Could generate millions at completion. (No indication of failure) Awaiting possible new award.
2. Hep C and positive results in India, with and without drugs.
Approved for commercailization. (No indication of failure)just waiting on patient pricing
3. Exosomes.....Wow, we currently have something that really no other company can do. Collected and even selectively collect different types of exosomes. Exosomes are being found in more then just cancer tumors. (No indication of failure)But based on communications there is a huge interest in Aethlon's work.
We were anticipating news last month, but then there was silence. So, with all the above with no indication of failure, do you really really think there will be bad new on the horizon? Listen to JJ's last two interviews. To me he seems honest and confident just like his presentations in the past, actually even more confident in his product.
With no indication of failure I'm hanging strong through the silence. I was a believer then and I'm still a long believer. GO AETHLON!
Sell? Out of the last several years I would say this is the best time to at least hold (IMO). To each their own, but my prediction is that the IDE is approved, DARPA grant, and India information comes through by the end of the year. Yes, within the month. It's easy to provide bad news, but takes silence and time for the good stuff. Either way good luck to you. Happy Holidays...
Would you buy, or hold?If we knew that the IDE was submitted, patient pricing established in India, and DARPA grant approved then it would be a no-brainer, but what would the price be? I'm going to buy tomorrow believing that the silence is only the calm before the storm of great news. Plus, I'm bored and there is not much else to do. Even holding is getting boring. Clicking the buy button is more fun then just staring at the screen. Hoping you all the best as we move into December.
So, who else besides me believes the IDE was already submitted? I'm actually really excited about Aethlons silence. I anticipate a very happy new year :) if we trust what's been said from the company this silence is embracing.
Just a recap....Three milestones that were anticipated last month
1. Pricing for patients in India
2. DARPA grant info
3. IDE submittal to FDA.
Now we have had silence for a month. This is getting good and you will see real soon that it was worth it. Stay positive because we might just get a great Holiday gift.
Hi Lee, I just cannot figure out what would be holding up Aethlon with preperation of the IDE. JJ seemed pretty clear that the IDE submittal was ready last month. Why the delay? The only thing I can think of is that Aethlon did not want to announce the submittal and then turn around a month or so later with an approval announcement. Since there is such a short time it would make sence to submit the IDE and only announce the approval. I'm going with the thought that Aethlon has been in communications with the FDA on their IDE submittal. Obviously this is just my guess and going by JJ's words in his last interview. This time I'm going to hold him to his word, since there have been no communications to counter this.
Happy Holidays
Well its been pretty quiet lately, so I thought I add my optimism before the Holidays :)
I re-listened to JJ's redchip interview and if your bored I'd suggest listening again between minutes 4:30-5:30 and towards the end at around 13:13.
JJ makes it pretty clear that there is a lot of focus on Aethlon and exosomes. He even says they are working on new corroberations, but then says he would like to be in a position to disclose them. So, are they working on it, or do they already have corroberation from the cancer industry? You can listen and judge the statement in your own way, but the way I look at it is why say "disclose" when corroborations have not yet been determined. I believe the IDE approval will set the ball rolling.
JJ also states that they are hoping for FDA approval by year end. Year end is closely approaching, which makes it pretty obvious that the IDE has already been submitted in the FDA. IMO
Here are a few of my thoughts. JJ makes it clear that exosomes are the near term focus for Aethlon. He makes it clear of the potential of exosomes in cancer care. He makes it clear that cancer organizations are clearly interested in Aethlon capabilities. So, with the current patents and possible ide approval where does it place Aethlon at the beginning of the year with FDA approval? Food for thought; If exosomes are the paradigm shift in cancer care wouldn't it be beneficial for a large cancer company to attempt to takeover Aethlon before Aethlon's true potential is known in the industry?
I know its been quiet and most believe that Aethlon's communications are non exsistent, but we have stayed with this company for so long because we believe. So, lets keep believing and allow the silence to be our success. We have been patient many times before, what's one more for the year. I truly believe we will have a great Christmas, and if not, then a great New Years.
Happy Holidays
Jeff